{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:38Z","timestamp":1792783178530,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the science and technology planning project of Guangdong province","award":["2017A020211029, 2011B061300065"],"award-info":[{"award-number":["2017A020211029, 2011B061300065"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s11010-021-04188-0","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T08:05:09Z","timestamp":1622102709000},"page":"3635-3646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["MiR-145 suppresses the motility of prostate cancer cells by targeting cadherin-2"],"prefix":"10.1007","volume":"476","author":[{"given":"Huixuan","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhu","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8042-6383","authenticated-orcid":false,"given":"Cairong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"4188_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21262","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21262","journal-title":"CA Cancer J Clin"},{"key":"4188_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020390","author":"S Monti","year":"2020","unstructured":"Monti S, Brancato V, Di Costanzo G, Basso L, Puglia M, Ragozzino A, Salvatore M, Cavaliere C (2020) Multiparametric MRI for prostate cancer detection: new insights into the combined use of a radiomic approach with advanced acquisition protocol. Cancers. https:\/\/doi.org\/10.3390\/cancers12020390","journal-title":"Cancers"},{"key":"4188_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-020-00567-9","author":"B Matos","year":"2020","unstructured":"Matos B, Patr\u00edcio D, Henriques MC, Freitas MJ, Vitorino R, Duarte IF, Howl J, Oliveira PA, Seixas F, Duarte JA, Ferreira R, Fardilha M (2020) Chronic exercise training attenuates prostate cancer-induced molecular remodelling in the testis. Cell Oncol. https:\/\/doi.org\/10.1007\/s13402-020-00567-9","journal-title":"Cell Oncol"},{"key":"4188_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fonc.2020.00582","volume":"10","author":"K Ried","year":"2020","unstructured":"Ried K, Tamanna T, Matthews S, Eng P, Sali A (2020) New screening test improves detection of prostate cancer using circulating tumor cells and prostate-specific markers. Front Oncol 10:582. https:\/\/doi.org\/10.3389\/fonc.2020.00582","journal-title":"Front Oncol"},{"issue":"4","key":"4188_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/jcb.24716","volume":"115","author":"X Xu","year":"2014","unstructured":"Xu X, Liu B, Zou P, Zhang Y, You J, Pei F (2014) Silencing of LASS2\/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell. J Cell Biochem 115(4):731\u2013743. https:\/\/doi.org\/10.1002\/jcb.24716","journal-title":"J Cell Biochem"},{"issue":"1","key":"4188_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41391-018-0079-0","volume":"22","author":"ED Crawford","year":"2019","unstructured":"Crawford ED, Heidenreich A, Lawrentschuk N, Tombal B, Pompeo ACL, Mendoza-Valdes A, Miller K, Debruyne FMJ, Klotz L (2019) Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations. Prostate Cancer Prostatic Dis 22(1):24\u201338. https:\/\/doi.org\/10.1038\/s41391-018-0079-0","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"4188_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.23736\/S0393-2249.18.03094-1","volume":"70","author":"E Linares-Espin\u00f3s","year":"2018","unstructured":"Linares-Espin\u00f3s E, Carneiro A, Mart\u00ednez-Salamanca JI, Bianco F, Castro-Alfaro A, Cathelineau X, Valerio M, Sanchez-Salas R (2018) New technologies and techniques for prostate cancer focal therapy. Minerva Urol Nefrol 70(3):252\u2013263. https:\/\/doi.org\/10.23736\/S0393-2249.18.03094-1","journal-title":"Minerva Urol Nefrol"},{"issue":"5","key":"4188_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.eururo.2017.01.039","volume":"72","author":"G Gandaglia","year":"2017","unstructured":"Gandaglia G, Briganti A, Clarke N, Karnes RJ, Graefen M, Ost P, Zietman AL, Roach M (2017) Adjuvant and salvage radiotherapy after radical prostatectomy in prostate cancer patients. Eur Urol 72(5):689\u2013709. https:\/\/doi.org\/10.1016\/j.eururo.2017.01.039","journal-title":"Eur Urol"},{"issue":"5","key":"4188_CR9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ceb.2012.05.014","volume":"24","author":"D Leckband","year":"2012","unstructured":"Leckband D, Sivasankar S (2012) Cadherin recognition and adhesion. Curr Opin Cell Biol 24(5):620\u2013627. https:\/\/doi.org\/10.1016\/j.ceb.2012.05.014","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"4188_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00223-013-9733-7","volume":"94","author":"PJ Marie","year":"2014","unstructured":"Marie PJ, Ha\u00ff E, Modrowski D, Revollo L, Mbalaviele G, Civitelli R (2014) Cadherin-mediated cell-cell adhesion and signaling in the skeleton. Calcif Tissue Int 94(1):46\u201354. https:\/\/doi.org\/10.1007\/s00223-013-9733-7","journal-title":"Calcif Tissue Int"},{"key":"4188_CR11","doi-asserted-by":"publisher","first-page":"109320","DOI":"10.1016\/j.biopha.2019.109320","volume":"118","author":"Z-Q Cao","year":"2019","unstructured":"Cao Z-Q, Wang Z, Leng P (2019) Aberrant N-cadherin expression in cancer. Biomed Pharmacother 118:109320. https:\/\/doi.org\/10.1016\/j.biopha.2019.109320","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4188_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc3647","volume":"14","author":"F van Roy","year":"2014","unstructured":"van Roy F (2014) Beyond E-cadherin: roles of other cadherin superfamily members in cancer. Nat Rev Cancer 14(2):121\u2013134. https:\/\/doi.org\/10.1038\/nrc3647","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"4188_CR13","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.ajpath.2019.06.016","volume":"189","author":"D Zhang","year":"2019","unstructured":"Zhang D, Yang X-J, Luo Q-D, Fu D-L, Li Z-L, Zhang P, Chong T (2019) Down-regulation of circular RNA_000926 attenuates renal cell carcinoma progression through miRNA-411-dependent CDH2 inhibition. Am J Pathol 189(12):2469\u20132486. https:\/\/doi.org\/10.1016\/j.ajpath.2019.06.016","journal-title":"Am J Pathol"},{"issue":"6","key":"4188_CR14","doi-asserted-by":"publisher","first-page":"a003129","DOI":"10.1101\/cshperspect.a003129","volume":"1","author":"G Berx","year":"2009","unstructured":"Berx G, van Roy F (2009) Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 1(6):a003129. https:\/\/doi.org\/10.1101\/cshperspect.a003129","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"4188_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12943-017-0751-3","volume":"17","author":"Y Liu","year":"2018","unstructured":"Liu Y, Chen X, Cheng R, Yang F, Yu M, Wang C, Cui S, Hong Y, Liang H, Liu M, Zhao C, Ding M, Sun W, Liu Z, Sun F, Zhang C, Zhou Z, Jiang X, Chen X (2018) The Jun\/miR-22\/HuR regulatory axis contributes to tumourigenesis in colorectal cancer. Mol Cancer 17(1):11. https:\/\/doi.org\/10.1186\/s12943-017-0751-3","journal-title":"Mol Cancer"},{"issue":"7441","key":"4188_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495(7441):384\u2013388. https:\/\/doi.org\/10.1038\/nature11993","journal-title":"Nature"},{"issue":"5","key":"4188_CR17","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.26355\/eurrev_202003_20531","volume":"24","author":"H Sheng","year":"2020","unstructured":"Sheng H, Guo YH, Cao DS, Li XJ, Zhao Y, Ding H, Zhang YL, Chen ZH (2020) MiR-429-5p attenuates the migration and invasion of malignant melanoma by targeting LIMK1. Eur Rev Med Pharmacol Sci 24(5):2625\u20132631. https:\/\/doi.org\/10.26355\/eurrev_202003_20531","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4188_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12935-020-1166-6","volume":"20","author":"Z Wei","year":"2020","unstructured":"Wei Z, Chang K, Fan C, Zhang Y (2020) MiR-26a\/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1. Cancer Cell Int 20:82. https:\/\/doi.org\/10.1186\/s12935-020-1166-6","journal-title":"Cancer Cell Int"},{"issue":"4","key":"4188_CR19","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1111\/jcmm.14966","volume":"24","author":"W Chen","year":"2020","unstructured":"Chen W, Song J, Bian H, Yang X, Xie X, Zhu Q, Qin C, Qi J (2020) The functions and targets of miR-212 as a potential biomarker of cancer diagnosis and therapy. J Cell Mol Med 24(4):2392\u20132401. https:\/\/doi.org\/10.1111\/jcmm.14966","journal-title":"J Cell Mol Med"},{"issue":"2","key":"4188_CR20","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/jcp.29066","volume":"235","author":"H Wang","year":"2020","unstructured":"Wang H, Yan B, Zhang P, Liu S, Li Q, Yang J, Yang F, Chen E (2020) MiR-496 promotes migration and epithelial-mesenchymal transition by targeting RASSF6 in colorectal cancer. J Cell Physiol 235(2):1469\u20131479. https:\/\/doi.org\/10.1002\/jcp.29066","journal-title":"J Cell Physiol"},{"issue":"5","key":"4188_CR21","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/0008-5472.CAN-19-1793","volume":"80","author":"F Citron","year":"2020","unstructured":"Citron F, Segatto I, Vinciguerra GLR, Musco L, Russo F, Mungo G, D\u2019Andrea S, Mattevi MC, Perin T, Schiappacassi M, Massarut S, Marchini C, Amici A, Vecchione A, Baldassarre G, Belletti B (2020) Downregulation of miR-223 expression is an early event during mammary transformation and confers resistance to CDK4\/6 inhibitors in luminal breast cancer. Cancer Res 80(5):1064\u20131077. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1793","journal-title":"Cancer Res"},{"issue":"8","key":"4188_CR22","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/carcin\/bgv063","volume":"36","author":"O Larne","year":"2015","unstructured":"Larne O, Hagman Z, Lilja H, Bjartell A, Edsj\u00f6 A, Ceder Y (2015) miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis. Carcinogenesis 36(8):858\u2013866. https:\/\/doi.org\/10.1093\/carcin\/bgv063","journal-title":"Carcinogenesis"},{"issue":"7","key":"4188_CR23","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1158\/0008-5472.CAN-09-3718","volume":"70","author":"X Chen","year":"2010","unstructured":"Chen X, Gong J, Zeng H, Chen N, Huang R, Huang Y, Nie L, Xu M, Xia J, Zhao F, Meng W, Zhou Q (2010) MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res 70(7):2728\u20132738. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3718","journal-title":"Cancer Res"},{"issue":"6","key":"4188_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/07357907.2015.1025407","volume":"33","author":"M Ozen","year":"2015","unstructured":"Ozen M, Karatas OF, Gulluoglu S, Bayrak OF, Sevli S, Guzel E, Ekici ID, Caskurlu T, Solak M, Creighton CJ, Ittmann M (2015) Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression. Cancer Invest 33(6):251\u2013258. https:\/\/doi.org\/10.3109\/07357907.2015.1025407","journal-title":"Cancer Invest"},{"issue":"7175","key":"4188_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nature06487","volume":"451","author":"SF Tavazoie","year":"2008","unstructured":"Tavazoie SF, Alarc\u00f3n C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagu\u00e9 J (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451(7175):147\u2013152. https:\/\/doi.org\/10.1038\/nature06487","journal-title":"Nature"},{"issue":"2 Pt B","key":"4188_CR26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.canlet.2014.11.011","volume":"356","author":"TH Kim","year":"2015","unstructured":"Kim TH, Song J-Y, Park H, Jeong J-Y, Kwon AY, Heo JH, Kang H, Kim G, An HJ (2015) miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma. Cancer Lett 356(2 Pt B):937\u2013945. https:\/\/doi.org\/10.1016\/j.canlet.2014.11.011","journal-title":"Cancer Lett"},{"issue":"9","key":"4188_CR27","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1111\/cas.14517","volume":"111","author":"W Xu","year":"2020","unstructured":"Xu W, Hua Y, Deng F, Wang D, Wu Y, Zhang W, Tang J (2020) MiR-145 in cancer therapy resistance and sensitivity: a comprehensive review. Cancer Sci 111(9):3122\u20133131. https:\/\/doi.org\/10.1111\/cas.14517","journal-title":"Cancer Sci"},{"issue":"11","key":"4188_CR28","first-page":"6739","volume":"11","author":"W-X Xu","year":"2019","unstructured":"Xu W-X, Liu Z, Deng F, Wang D-D, Li X-W, Tian T, Zhang J, Tang J-H (2019) MiR-145: a potential biomarker of cancer migration and invasion. Am J Transl Res 11(11):6739\u20136753","journal-title":"Am J Transl Res"},{"issue":"3","key":"4188_CR29","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ymthe.2017.12.023","volume":"26","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Wang C, Becker SA, Hurst K, Nogueira LM, Findlay VJ, Camp ER (2018) miR-145 antagonizes SNAI1-mediated stemness and radiation resistance in colorectal cancer. Mol Ther 26(3):744\u2013754. https:\/\/doi.org\/10.1016\/j.ymthe.2017.12.023","journal-title":"Mol Ther"},{"issue":"7","key":"4188_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nrurol.2013.113","volume":"10","author":"H Yoshino","year":"2013","unstructured":"Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M, Enokida H (2013) Aberrant expression of microRNAs in bladder cancer. Nat Rev Urol 10(7):396\u2013404. https:\/\/doi.org\/10.1038\/nrurol.2013.113","journal-title":"Nat Rev Urol"},{"issue":"12","key":"4188_CR31","doi-asserted-by":"publisher","first-page":"7528","DOI":"10.1093\/nar\/gku461","volume":"42","author":"OA Kent","year":"2014","unstructured":"Kent OA, McCall MN, Cornish TC, Halushka MK (2014) Lessons from miR-143\/145: the importance of cell-type localization of miRNAs. Nucleic Acids Res 42(12):7528\u20137538. https:\/\/doi.org\/10.1093\/nar\/gku461","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"4188_CR32","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1158\/0008-5472.can-07-0533","volume":"67","author":"KP Porkka","year":"2007","unstructured":"Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T (2007) MicroRNA expression profiling in prostate cancer. Cancer Res 67(13):6130\u20136135. https:\/\/doi.org\/10.1158\/0008-5472.can-07-0533","journal-title":"Cancer Res"},{"issue":"12","key":"4188_CR33","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/sj.onc.1210809","volume":"27","author":"M Ozen","year":"2008","unstructured":"Ozen M, Creighton CJ, Ozdemir M, Ittmann M (2008) Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27(12):1788\u20131793. https:\/\/doi.org\/10.1038\/sj.onc.1210809","journal-title":"Oncogene"},{"issue":"8","key":"4188_CR34","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes J, Peruzzi PP, Lawler S (2014) MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20(8):460\u2013469. https:\/\/doi.org\/10.1016\/j.molmed.2014.06.005","journal-title":"Trends Mol Med"},{"key":"4188_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051310","author":"JJ Chan","year":"2018","unstructured":"Chan JJ, Tay Y (2018) Noncoding RNA:RNA regulatory networks in cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19051310","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4188_CR36","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.urolonc.2014.01.003","volume":"32","author":"B Kou","year":"2014","unstructured":"Kou B, Gao Y, Du C, Shi Q, Xu S, Wang CQ, Wang X, He D, Guo P (2014) miR-145 inhibits invasion of bladder cancer cells by targeting PAK1. Urol Oncol 32(6):846\u2013854. https:\/\/doi.org\/10.1016\/j.urolonc.2014.01.003","journal-title":"Urol Oncol"},{"key":"4188_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.biopha.2018.10.037","volume":"109","author":"T Zeinali","year":"2019","unstructured":"Zeinali T, Mansoori B, Mohammadi A, Baradaran B (2019) Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis. Biomed Pharmacother 109:195\u2013207. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.037","journal-title":"Biomed Pharmacother"},{"issue":"21","key":"4188_CR38","doi-asserted-by":"publisher","first-page":"10816","DOI":"10.18632\/oncotarget.2522","volume":"5","author":"R Dong","year":"2014","unstructured":"Dong R, Liu X, Zhang Q, Jiang Z, Li Y, Wei Y, Li Y, Yang Q, Liu J, Wei JJ, Shao C, Liu Z, Kong B (2014) miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma. Oncotarget 5(21):10816\u201310829. https:\/\/doi.org\/10.18632\/oncotarget.2522","journal-title":"Oncotarget"},{"issue":"2","key":"4188_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/jhg.2013.121","volume":"59","author":"S Kojima","year":"2014","unstructured":"Kojima S, Enokida H, Yoshino H, Itesako T, Chiyomaru T, Kinoshita T, Fuse M, Nishikawa R, Goto Y, Naya Y, Nakagawa M, Seki N (2014) The tumor-suppressive microRNA-143\/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer. J Hum Genet 59(2):78\u201387. https:\/\/doi.org\/10.1038\/jhg.2013.121","journal-title":"J Hum Genet"},{"issue":"1","key":"4188_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3892\/mmr.2014.2149","volume":"10","author":"D Wu","year":"2014","unstructured":"Wu D, Li M, Wang L, Zhou Y, Zhou J, Pan H, Qu P (2014) microRNA-145 inhibits cell proliferation, migration and invasion by targeting matrix metallopeptidase-11 in renal cell carcinoma. Mol Med Rep 10(1):393\u2013398. https:\/\/doi.org\/10.3892\/mmr.2014.2149","journal-title":"Mol Med Rep"},{"issue":"2","key":"4188_CR41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/nar\/gkr730","volume":"40","author":"Q Xu","year":"2012","unstructured":"Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, Li D, Lai L, Jiang BH (2012) MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res 40(2):761\u2013774. https:\/\/doi.org\/10.1093\/nar\/gkr730","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"4188_CR42","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1111\/jcmm.13604","volume":"22","author":"D Xue","year":"2018","unstructured":"Xue D, Lu H, Xu H-Y, Zhou C-X, He X-Z (2018) Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12. J Cell Mol Med 22(6):3223\u20133237. https:\/\/doi.org\/10.1111\/jcmm.13604","journal-title":"J Cell Mol Med"},{"issue":"12","key":"4188_CR43","doi-asserted-by":"publisher","first-page":"e0166189","DOI":"10.1371\/journal.pone.0166189","volume":"11","author":"R De Gasperi","year":"2016","unstructured":"De Gasperi R, Graham ZA, Harlow LM, Bauman WA, Qin W, Cardozo CP (2016) The signature of MicroRNA dysregulation in muscle paralyzed by spinal cord injury includes downregulation of MicroRNAs that target myostatin signaling. PLoS ONE 11(12):e0166189. https:\/\/doi.org\/10.1371\/journal.pone.0166189","journal-title":"PLoS ONE"},{"issue":"8","key":"4188_CR44","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1158\/1541-7786.MCR-12-0261","volume":"10","author":"H Ko","year":"2012","unstructured":"Ko H, Kim S, Jin C-H, Lee E, Ham S, Yook JI, Kim K (2012) Protein kinase casein kinase 2-mediated upregulation of N-cadherin confers anoikis resistance on esophageal carcinoma cells. Mol Cancer Res 10(8):1032\u20131038. https:\/\/doi.org\/10.1158\/1541-7786.MCR-12-0261","journal-title":"Mol Cancer Res"},{"key":"4188_CR45","doi-asserted-by":"publisher","first-page":"4837","DOI":"10.2147\/OTT.S169101","volume":"11","author":"S Gao","year":"2018","unstructured":"Gao S, Zhao Z, Wu R, Wu L, Tian X, Zhang Z (2018) MicroRNA-194 regulates cell viability and apoptosis by targeting CDH2 in prostatic cancer. Onco Targets Ther 11:4837\u20134844. https:\/\/doi.org\/10.2147\/OTT.S169101","journal-title":"Onco Targets Ther"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04188-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04188-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04188-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T06:45:55Z","timestamp":1629701155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04188-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["4188"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04188-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"assertion":[{"value":"20 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have any relevant conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of the first affiliated hospital of Jinan university.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors have given their consent for publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}